Novavax scores narrower Covid vaccine approval
Digest more
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b
Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing plan announced last week by President Donald Trump.
Moderna (MRNA), and Novavax (NVAX) agree as the FDA advisors recommend targeting JN.1 strain for updated COVID vaccines this fall. Read more here.